Scilex Holding Co
corporate_fare Company Profile
Scilex Holding Co (NASDAQ:SCLX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 31 items for SCLX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for SCLX spans 8-K, 4, 10-Q, SCHEDULE 13D/A.
Recent high-impact activity:
- Scilex Hit With Nasdaq Notice: Market Value Below $35M Minimum, All Three Listing Standards Failed
- Scilex Dismisses Auditor BPM, Appoints Pipara & Co. Amid Going-Concern Doubts
- Scilex Taps $15.8M from Vivasor Credit Line, Paying with 50M Datavault AI Shares
- Scilex Posts $115M Q2 Loss, Cash Dwindles to $0.6M, Going Concern Doubt Reiterated
- Scilex Unwinds Vivasor Stake in $12M Related-Party Sale
Financial Snapshot
Short Interest & Short Volume
3.37 days to coverFINRA reported short interest of 132,205 shares in SCLX as of the October 30, 2026 settlement, a 10.9% decrease from the prior period — about 3.4 days to cover at its recent average daily volume. On November 20, 2026, 40.3% of SCLX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for SCLX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-24.
Equity Incentive Plan Expanded · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →